Page last updated: 2024-09-03

vadimezan and Leukemia, Myeloid, Acute

vadimezan has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Corrales, L; Curran, E; Dubensky, TW; Duttagupta, P; Kline, DE; Kline, J; Kortylewski, M	1

Other Studies

1 other study(ies) available for vadimezan and Leukemia, Myeloid, Acute

Article	Year
STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia. Cell reports, 2016, 06-14, Volume: 15, Issue:11 Topics: Adaptive Immunity; Animals; Antigen-Presenting Cells; Antigens, Neoplasm; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Genetic Engineering; Humans; Immunity, Innate; Immunologic Memory; Interferon Type I; Leukemia, Myeloid, Acute; Membrane Proteins; Mice, Inbred C57BL; Signal Transduction; Survival Analysis; Xanthones	2016

Article

Year

STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia.

Cell reports, 2016, 06-14, Volume: 15, Issue:11

Topics: Adaptive Immunity; Animals; Antigen-Presenting Cells; Antigens, Neoplasm; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Genetic Engineering; Humans; Immunity, Innate; Immunologic Memory; Interferon Type I; Leukemia, Myeloid, Acute; Membrane Proteins; Mice, Inbred C57BL; Signal Transduction; Survival Analysis; Xanthones

2016